Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Cox

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Cancer Research|February 28, 2007
Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal womenChristopher A Haiman, Laure Dossus, V Wendy Setiawan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2007
CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)Veronica Wendy Setiawan, Fredrick R Schumacher, Christopher A Haiman, et al.
Carcinogenesis|December 8, 2009
PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3)Laure Dossus, Rudolf Kaaks, Federico Canzian, et al.
Plos One|February 14, 2014
A genome-wide "pleiotropy scan" does not identify new susceptibility loci for estrogen receptor negative breast cancerDaniele Campa, Myrto Barrdahl, Konstantinos K Tsilidis, et al.
International Journal of Cancer|March 5, 2014
Active and passive cigarette smoking and breast cancer risk: results from the EPIC cohortLaure Dossus, Marie-Christine Boutron-Ruault, Rudolf Kaaks, et al.
Human Molecular Genetics|June 5, 2014
Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 womenMyrto Barrdahl, Federico Canzian, Amit D Joshi, et al.
Human Molecular Genetics|July 17, 2010
Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortiumFederico Canzian, David G Cox, V Wendy Setiawan, et al.
Nature Communications|August 11, 2018
Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibilityMitchell J Machiela, Thomas G P Grünewald, Didier Surdez, et al.
Nature Genetics|March 31, 2009
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)Gilles Thomas, Kevin B Jacobs, Peter Kraft, et al.
JAMA Oncology|May 27, 2016
Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United StatesPaige Maas, Myrto Barrdahl, Amit D Joshi, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Cancer Research|February 28, 2007
Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal womenChristopher A Haiman, Laure Dossus, V Wendy Setiawan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2007
CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)Veronica Wendy Setiawan, Fredrick R Schumacher, Christopher A Haiman, et al.
Carcinogenesis|December 8, 2009
PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3)Laure Dossus, Rudolf Kaaks, Federico Canzian, et al.
Plos One|February 14, 2014
A genome-wide "pleiotropy scan" does not identify new susceptibility loci for estrogen receptor negative breast cancerDaniele Campa, Myrto Barrdahl, Konstantinos K Tsilidis, et al.
International Journal of Cancer|March 5, 2014
Active and passive cigarette smoking and breast cancer risk: results from the EPIC cohortLaure Dossus, Marie-Christine Boutron-Ruault, Rudolf Kaaks, et al.
Human Molecular Genetics|June 5, 2014
Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 womenMyrto Barrdahl, Federico Canzian, Amit D Joshi, et al.
Human Molecular Genetics|July 17, 2010
Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortiumFederico Canzian, David G Cox, V Wendy Setiawan, et al.
Nature Communications|August 11, 2018
Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibilityMitchell J Machiela, Thomas G P Grünewald, Didier Surdez, et al.
Nature Genetics|March 31, 2009
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)Gilles Thomas, Kevin B Jacobs, Peter Kraft, et al.
JAMA Oncology|May 27, 2016
Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United StatesPaige Maas, Myrto Barrdahl, Amit D Joshi, et al.
Pageof 11